Iron Long-Term Labelling Study Benin

NCT02979080 | Unknown

• 1 other identifier: Fe_LTL_Be
• Study Type: interventional
• Target: 63
• Locations: 1 country
• Sites: 2

Brief Summary

Conventional indirect indicators of iron status, using serum and red blood cell biomarkers, are confounded by inflammation from common infections in sub-Saharan Africa, a region with a high prevalence of iron deficiency, making the assessment of iron balance and efficiency of iron intervention difficult. A potential reference method to quantify iron absorption and requirements using isotope dilution measurements in women living in areas with high burden of infection should be developed and validated within this project. The new method will allow accurate measurement of long term oral iron absorption and the estimation of iron requirements, potentially providing fundamental guidance for supplementation and fortification programs in sub-Saharan Africa. In a case series with four months' preventative iron supplementation intervention imbedded between a four months' control period prior intervention and a four months' control period after intervention, we will follow a group of 63 women. During the intervention period, the women will receive 50 mg Fe as ferrous sulfate tablets every day for 120 d. In total, the women will give 9 blood samples (day 1, 60 120, 150, 180, 210, 240, 300 and 360) for the de-termination of the isotopic composition and iron status biomarkers and 5 stool samples (day 1, 120, 180, 240 and 360) for the detection of soil transmitted helminths and gut inflammation. This design will allow the measurement of the isotopic iron dilution to assess the total oral iron absorption during the intervention period in comparison with the control periods without the administration of additional iron isotopes.

Conditions

Iron Absorption

Outcome Measures

Primary Outcomes (1)

• iron isotope composition in blood

  1 year

Study Arms (1)

Oral Iron Supplementation

EXPERIMENTAL

Eisensulfat LOMAPHARM 50 mg administration for 120 days

Other: Eisensulfat LOMAPHARM 50 mg

Interventions

Eisensulfat LOMAPHARM 50 mg OTHER

Eisensulfat LOMAPHARM 50 mg administration for 120 days

Oral Iron Supplementation

Eligibility Criteria

• Age: 18 Years - 50 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Have participated in one of the original absorption studies
• Signed written informed consent to participate in the study

You may not qualify if:

• Long-term medication \[except contraceptives\]
• Any severe metabolic, gastrointestinal kidney or chronic disease such as diabetes, hepatitis, hypertension, cancer or cardiovascular diseases according to the participants own statement or examination of study doctor
• Blood losses \[surgery, accident\], donations or transfusions during the past 4 months before study start.
• Residence too far away \[1 hour or more by motorbike\] from study locations; Natitingou or Cotonou

Sponsors & Collaborators

• Prof. Michael B. Zimmermann: lead

Study Sites (2)

Hôpital de zone de Natitingou

Natitingou, Atakora Department, Benin

Location

Hôpital de zone d'Abomey-Calavi-Sô-Ava

Abomey-Calavi, Calavi, Benin

Location

Related Publications (1)

• Speich C, Mitchikpe CES, Cercamondi CI, Zeder C, Brittenham GM, Moretti D, Zimmermann MB. Direct assessment of body iron balance in women with and without iron supplementation using a long-term isotope dilution method in Benin and Switzerland. Am J Clin Nutr. 2021 Jun 1;113(6):1657-1669. doi: 10.1093/ajcn/nqaa433.

  PMID: 33693464 DERIVED

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: November 29, 2016
• First Posted: December 1, 2016
• Study Start: June 10, 2017
• Primary Completion: June 30, 2018
• Study Completion: August 31, 2019
• Last Updated: October 9, 2018

Record last verified: 2018-10

Data Sharing

• IPD Sharing: Will not share

Locations

BE (2)